Evidence map›Paper›PMID 35748681›Full record

ArticleTransfusion2022

In vitro quality and hemostatic function of cold-stored CPDA-1 whole blood after repeated transient exposure to 28°C storage temperature.

Joar Sivertsen, Tor Hervig, Geir Strandenes, Einar K Kristoffersen, Hanne Braathen, Torunn O Apelseth

Open access · bronzeAbstract read
In one paragraph

Article in Transfusion, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joar SivertsenDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0001-5501-5486
Tor HervigDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0001-9441-253X
Geir StrandenesDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-3168-3786
Einar K KristoffersenDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.
Hanne BraathenDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-4750-0681
Torunn O ApelsethDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0001-8823-2719
Haukeland University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood products are frequently exposed to room temperature or higher for longer periods than permitted by policy. We aimed to investigate if this resulted in a measurable effect on common quality parameters and viscoelastic hemostatic function of cold stored CPDA-1 whole blood. STUDY DESIGN AND

methods450 ml of whole blood from 16 O Rh(D) positive donors was collected in 63 ml of CPDA-1 and stored cold. Eights bags were exposed to five weekly 4-h long transient temperature changes to 28°C. Eight bags were stored continuously at 4°C as a control. Samples were collected at baseline on day 1, after the first cycle on day 1 and weekly before each subsequent cycle (day 7, 14, 21, 28 and 35). Hemolysis, hematological parameters, pH, glucose, lactate, potassium, thromboelastography, INR, APTT, fibrinogen, and factor VIII were measured.

resultsCPDA-1 whole blood repeatedly exposed to 28°C did not show reduced quality compared to the control group on day 35. Two units in the test group had hemolysis of 1.1% and 1.2%, and two in the control group hemolysis of 0.8%. Remaining thromboelastography clot strength (MA) on day 35 was 51.7 mm (44.8, 58.6) in the test group and 46.1 (41.6, 50.6) in the control group (p = .023). Platelet count was better preserved in the test group (166.7 [137.8, 195.6] vs. 117.8 [90.3, 145.2], p = .018). One sample in the test group was positive for Cutibacterium acnes on day 35 + 6.

conclusionHemolysis findings warrant further investigation. Other indicators of quality were not negatively affected.

Indexed as

Blood PreservationHemostaticsAdenineCitratesGlucoseHemolysisHumansPhosphatesPlatelet CountTemperatureAdenineCitratesCPDA solutionsGlucoseHemostaticsPhosphatesCPDA-1storage lesionstorage temperaturetemperature violationswhole blood

Identifiers

PMID35748681
PMCPMC9541954
OpenAlexW4283395141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.